Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Considering the Danish payer perspective to estimate incremental cost-effectiveness ratios (DKK/QALY), base case deterministic analyses were conducted using a 40-year time horizon, where Swedish NDR macrovascular and UKPDS 82 mortality risk equations were selected
GLP-1 Medications Vs
One of the key trials, SUSTAIN 6, found that semaglutide lowered the risk of major cardiovascular events in high-risk patients with diabetes
They are committed to quality and a streamlined experience
US$ 22.70
US$ 29.59
US$ 22.48
US$ 25.43
US$ 23.84
US$ 25.95
US$ 25.65
